Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	51.75	-5.87	-12.18
Graham Fair Price	73.70	0.08	0.05
PEG	38.05	< 0.005	< 0.005
Price/Book	-5.81	3.58	3.80
Price/Cash Flow	-51.30	9.14	18.78
Prices/Earnings	52.91	-0.86	-1.82
Price/Sales	-52.91	2.52	5.34
Price/FCF	-51.30	9.14	18.78
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-4.27	0.31	0.32
Operating Margin	-0.87	-0.64	-0.64
ROA	-100.00	-0.19	-0.10
ROE	-0.52	-1.05	-100.00
ROIC	-0.18	-0.36	-100.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.33	-97.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-14.70	-1.02	93.08
EPS QOQ	-1.92	-1.46	23.98
FCF QOQ	5.72	0.93	-83.68
Revenue QOQ	-0.07	1.00	1266.31
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	310.48	152.13	-51.00
Days Sales Outstanding (DSO)	447.31	226.18	-49.44
Inventory Turnover	0.29	0.59	104.09
Debt/Capitalization	0.63	0.63	0.27
Quick Ratio	1.02	1.03	1.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.01	0.02	22.82
Cash	< 0.005	< 0.005	22.82
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	137.57
Revenue	< 0.005	0.02	145.65
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.47	1.47	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.73	-1.88	49.47
Naive Interpretation	Member

06 - Financial Health · Weak

Rating